Skip to content

Study on the Tumor Biology and Safety of Breast Cancer Edema Skin

Study on the Tumor Biology and Safety of Breast Cancer Edema Skin

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104872
Enrollment
Unknown
Registered
2025-06-25
Start date
2025-07-20
Completion date
Unknown
Last updated
2025-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Case series:None

Sponsors

Hubei Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Diagnosed as breast cancer patients through clinical pathological diagnosis (Age = 18 years old with ECOG score of 0-1); 2. Accompanied by localized edema of the breast skin (determined by clinical examination or imaging assessment); 3. Subjects included are newly diagnosed breast cancer patients who have not received any treatment for breast cancer prior to enrollment; 4. Patients judged by the investigator to have surgical opportunities, or expected to gain surgical opportunities after neoadjuvant therapy; 5. Approved by the ethics committee of our hospital.

Exclusion criteria

Exclusion criteria: 1. Mentally ill individuals; 2. Individuals with physical conditions unsuitable for surgery; 3. Those with other primary tumors or distant metastases; 4. Individuals with extensive inflammatory breast or skin involvement; 5. Those for whom clinical examination and breast ultrasound cannot determine skin edema; 6. Individuals with incomplete preoperative imaging data or postoperative pathological data; 7. Pregnant or breastfeeding women; 8. Those who have not signed the informed consent for treatment.

Design outcomes

Primary

MeasureTime frame
Whether there is cancer cell infiltration in the dermis and subcutaneous fat layer at each detection point;

Secondary

MeasureTime frame
The expression of CD68 in the dermis and subcutaneous fat layer of each detection point;The expression of CD20 in the dermis and subcutaneous fat layer of each detection point;The expression of CD20 in the dermis and subcutaneous fat layer of each detection point;

Countries

China

Contacts

Public ContactWu Xinhong

Hubei Cancer Hospital

369423971@qq.com+86 186 0272 6300

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026